Source: Eur Respir J, 58 (2) 2100920; 10.1183/13993003.00920-2021
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Peter A.B. Wark, Prabuddha S. Pathinayake, Mathew Suji Eapen, Sukhwinder Singh Sohal. Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights. Eur Respir J, 58 (2) 2100920; 10.1183/13993003.00920-2021

Member's Comments

No comment yet.

Related content which might interest you: The consequences of novel insights into the pathophysiology of asthma for its treatment Source: Annual Congress 2008 - Should asthma no longer be considered an allergic disease? Year: 2008 Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Respiratory viral infection: a potential “missing link” in the pathogenesis of COPD Source: Eur Respir Rev, 28 (151) 180063; 10.1183/16000617.0063-2018 Year: 2019 Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology Source: ERS Satellites 2021 Year: 2021 Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010 Biological and therapeutic implications of the united airways disease concept Source: Annual Congress 2005 - PG18 - Inter-relationships between upper and lower airway diseases Year: 2005 The link between fungi and severe asthma: a summary of the evidence Source: Eur Respir J 2006; 27: 615-626 Year: 2006 COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Identification of therapeutic targets for steroid-insensitive asthma using models that represent different clinical subtypes of disease Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient Year: 2015 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Severe asthma in Asia: insight into phenotypes Source: International Congress 2016 – Molecular phenotyping of severe asthma Year: 2016 Cytokine patterns and latent viruses in patients with severe asthma and COPD Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Attitudes and actions of asthma patients in Korea: asthma insight survey Source: Annual Congress 2008 - Asthma and miscellaneous disorders Year: 2008 Additive layer manufacturing of physiologically realistic patient specific airway models for study of flow modifications in asthma and COPD Source: Annual Congress 2013 –Functional imaging Year: 2013 New genetics and epigenetics insights in paediatric asthma Source: International Congress 2017 – Omics in paediatric asthma and beyond Year: 2017 New insights into pathogenesis of bronchiectasis Source: Annual Congress 2012 - Update on bronchiectasis Year: 2012